Optometry News

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Adam Turpcu, PhD, of Adverum Biotechnologies discusses Ixo-vec for neovascular age-related macular degeneration.

Genentech is set to reintroduce Susvimo for patients with wet age-related macular degeneration nearly 2 years after it voluntarily recalled the ocular implant, according to a press release.

Age-related macular degeneration is the leading cause of vison loss among older adults.

SEATTLE — A virtual reality headset for pupillometry may be able to screen for and detect relative afferent pupillary defects, according to a poster presented at the Association for Research in Vision and Ophthalmology meeting.

The Vision Council has released new research about the experiences, diagnoses, information sources and treatment options for patients with low vision, as well as the effect of their condition on primary caregivers.

In the last post, I introduced the concept of AI content engines and how they can significantly leverage your marketing efforts via multiple technologies and across multiple channels.

Like many sports, such as soccer and basketball, financial independence requires simultaneous offense and defense. One of the most important defensive plays a physician must make is buying disability insurance.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Carolyn Sasse of Astellas highlights the company’s ophthalmology pipeline.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Ramanath Bhandari, MD, FASRS, of RevOpsis Therapeutics discusses the development of RO-104 for the treatment of retinal disease.

The FDA approved the Vabysmo 6-mg single-dose prefilled syringe for the treatment of wet age-related macular degeneration, diabetic macular edema and macular edema following retinal vein occlusion, according to a Genentech press release.